What compounded semaglutide is
Semaglutide is a GLP-1 receptor agonist: a medicine that acts on the receptor for GLP-1, a hormone your gut releases after you eat. Compounded semaglutide is that ingredient prepared by a licensed pharmacist for one person’s prescription, rather than made by a drug company as a finished product [1]. The compounded semaglutide prescribed through VevaMD comes with vitamin B12 in the same vial, and it is prepared by NewLife Rx, a state-licensed 503A pharmacy, only after a physician writes the prescription.
Three facts define it. It is compounded and not FDA-approved: the FDA does not review compounded drugs for safety, effectiveness or quality before they are sold [1]. It is not a generic: a generic drug is FDA-approved and has to establish therapeutic equivalence with its brand, and a compounded drug is not approved at all [1]. It is not Wegovy® or Ozempic®, the semaglutide products Novo Nordisk makes, so this page uses no numbers from their trials.
How VevaMD prescribes it
The FDA lists red flags for buying a GLP-1 online: no screening by a licensed doctor, no doctor to answer questions once the medicine arrives, a pharmacy you cannot check, and claims that a compounded drug matches an approved one [2]. VevaMD is built the other way around.
- A physician decides. A board-certified, US-licensed physician reviews your intake, can message you, order labs or ask for a video visit, and can say no. If nothing is prescribed, your first payment is refunded in full.
- A named, state-licensed pharmacy. The FDA notes that people who buy compounded drugs online often do not know who compounded them [1]. Yours is prepared by NewLife Rx, a 503A pharmacy overseen by its state board of pharmacy, and shipped to your door.
- One price, shown before you pay. As low as $199/mo, covering the physician, the medication and shipping, the same at every dose, with no membership fee on compounded plans.
- Care that continues. Your physician manages the plan as the amount goes up and checks in over time, and the VevaMD team answers questions about your order by phone or email.
- Every option in one place. If an FDA-approved brand is the better fit, the same intake can lead to Wegovy® or Zepbound®.
Who it may be for, and who it is not for
May be for
- Adults with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure or type 2 diabetes: the group NIDDK describes for weight-management medicines [3]
- People who have worked on eating and activity and want a medicine alongside it; the Endocrine Society calls medicines for chronic weight management useful adjuncts to lifestyle change [4]
- People comfortable giving themselves a small weekly injection under the skin
- People who want one predictable monthly price that does not climb as the amount goes up
Not for
- Anyone with a personal or family history of medullary thyroid carcinoma (MTC), or with multiple endocrine neoplasia syndrome type 2 (MEN 2) [5]
- Anyone who is pregnant or breastfeeding; the Wegovy® label advises stopping semaglutide at least 2 months before a planned pregnancy [5]
- Anyone who has had a serious allergic reaction to semaglutide [5]
- Anyone already on another GLP-1 medicine, such as Ozempic® or Mounjaro®; the label advises against combining them [5]
- People with severe gastroparesis [5]
- People with type 1 diabetes
How semaglutide works
Your gut releases GLP-1 after a meal as a fullness signal, but it lasts only minutes. Semaglutide is built to resemble it and to last a week. The Wegovy® label describes semaglutide acting on GLP-1 receptors in the brain areas that regulate appetite and calorie intake, and slowing how fast the stomach empties [5]. NIDDK puts the effect in plain terms: some weight-management medicines help you feel less hungry, or full sooner [3].
Your physician starts low and raises the amount step by step over several weeks. That keeps stomach side effects down, and the Obesity Medicine Association notes that many patients start at a lower dose and work up [6]. You get the plan in writing, and the price does not change as the amount rises.
The medication comes as a liquid in a small multi-dose vial. You draw each weekly amount into a new, sterile syringe and inject it under the skin. Two FDA handling points apply to any vial like it: injectable GLP-1 medicines need refrigeration, so do not use one that arrives warm, and a multi-dose vial is discarded 28 days after the first use even if some is left [2].
What to expect over time
- Before you startA private online intake about your weight, your health history and every medicine you take. A physician reviews it and decides whether to prescribe.
- The first weeksYou begin at the lowest amount. Nausea, early fullness and changes in bowel habits are most likely now, while your body adjusts [6].
- The first monthsYour physician raises the amount in steps as you tolerate it. Each step is a check-in on how you feel, your side effects, and whether to hold or go up.
- At the full amountNIDDK’s rule of thumb for any weight-management medicine: after 12 weeks on the full dose, your health care professional looks at whether you have lost at least 5% of your starting weight and decides whether to continue or change course [3].
- Long termObesity is a chronic disease, and NIDDK says most people regain some weight after they stop a weight-management medicine [3]. Your physician keeps managing the plan for as long as you stay on it.
Side effects and risks
Compounded semaglutide has no FDA label of its own. The risks below are the ones the FDA-approved Wegovy® label lists for semaglutide made by Novo Nordisk, and your physician reviews them with you.
- Most common: nausea, diarrhea, vomiting, constipation and stomach pain, most often while the amount is going up [5].
- Serious but less common: inflammation of the pancreas, gallbladder disease, kidney injury from dehydration, severe stomach side effects, serious allergic reactions, a faster resting heart rate, low blood sugar when taken with insulin or a sulfonylurea, and worsening eye disease in people with diabetic retinopathy [5].
- Before surgery or sedation: semaglutide slows stomach emptying, and rare cases of food entering the lungs under anesthesia have been reported with GLP-1 medicines, so tell anyone doing a procedure that you take it [5].
- Pregnancy: it may harm an unborn baby, so it is stopped when a pregnancy is recognized [5].
One FDA point is specific to vials: the agency has received reports of dosing errors with compounded semaglutide, from amounts measured incorrectly, and asks patients to confirm with their prescriber or pharmacy exactly how to measure each dose [2]. Your physician’s written plan is there for that.
What the FDA says about compounded semaglutide
Semaglutide injection was on the FDA’s shortage list from 2022. On February 21, 2025 the FDA declared that shortage resolved, so pharmacies can no longer rely on it to compound semaglutide [7]. A state-licensed 503A pharmacy compounds it for an individual patient’s prescription, under its state board of pharmacy [1]. On April 30, 2026 the FDA proposed leaving semaglutide off the list of bulk ingredients that large outsourcing facilities, known as 503B, may use; that proposal is about outsourcing facilities, not 503A pharmacies [8].
VevaMD follows the FDA’s rules for how telehealth companies describe a compounded GLP-1: never calling it FDA-approved, never claiming trials show it matches a brand, and naming the pharmacy that makes it [9]. (The FDA’s general position is that compounded drugs are for patients whose needs an FDA-approved drug cannot meet [1]; Wegovy® is available through the same intake.) Read more about compounded medications.
Compared with the other GLP-1 options
Every GLP-1 option at VevaMD starts from the same intake, and your physician recommends one. Compounded tirzepatide acts on a second gut-hormone receptor as well as GLP-1. Wegovy® and Zepbound® are the FDA-approved brands, through a membership.
| FDA status | How it is taken | How you pay at VevaMD | Main trade-offs | |
|---|---|---|---|---|
| Compounded semaglutide | Compounded, not FDA-approved | Weekly injection from a vial, with vitamin B12 | One monthly price, as low as $199/mo: physician, medication and shipping. No membership fee | The lowest monthly price, the same at every dose; you draw each dose with a syringe |
| Compounded tirzepatide | Compounded, not FDA-approved | Weekly injection from a vial, with vitamin B12 | One monthly price, as low as $299/mo: physician, medication and shipping. No membership fee | Acts on two gut-hormone receptors, GLP-1 and GIP; the same price at every dose; you draw each dose with a syringe |
| Wegovy® | FDA-approved brand | Weekly prefilled pen, or a daily tablet | A $149/mo VevaMD membership, plus the self-pay price paid to Novo Nordisk ($348–$498/mo in total for the pen) | Approved for weight and to lower heart risk in adults with heart disease; pen or pill; two separate charges |
| Zepbound® | FDA-approved brand | Weekly prefilled pen | A $149/mo VevaMD membership, plus the self-pay price paid to Eli Lilly ($448–$598/mo in total) | Approved for weight and for moderate to severe sleep apnea with obesity; prefilled pen; two separate charges |
Weight gain in perimenopause and menopause
Gaining weight in midlife is one of the most common concerns women bring to a physician. The Menopause Society says aging is the main driver, while the fall in estrogen at menopause moves fat toward the abdomen, where it carries more heart and metabolic risk. Hot flashes and broken sleep make healthy habits harder to keep [10].